Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Renaissance Washington DC Dupont Circle Hotel

Oct 27, 2016 8:15 AM - Oct 28, 2016 5:00 PM

Formerly Renaissance M Street Hotel, 1143 New Hampshire Avenue, NW, , Washington, DC 20037 , USA

Biosimilars 2016

Preview the New Agenda for DIA Biosimilars 2016, the Premier Global Biosimilars Conference.

Session 8: Patient Access

Session Chair(s)

Michael  Muenzberg

Michael Muenzberg

Vice President, Director Medical Affairs Biosimilars

Ares Trading S.A, Switzerland

Biologic medicines play an increasing role in the patient care across a growing number of disease areas. Access to these modern therapies remains restricted due to the high cost of these medicines. This session will look at the current barriers to accessing existing biologic therapies and how the emergence of biosimilar medicines across Europe and in the US brings the promise to overcome those, offering opportunities for health systems to expand access for more patients, but also foster investment in new areas of care while providing relief on health care budgets.

Speaker(s)

Paulo  Moreira

Increasing Information for Patients About Accessing Treatments Biosimilars and Clinical Trials

Paulo Moreira

Agenus, United States

Global Head of Clinical Operations

John  Carlsen, MHA

An Overview of Current Biosimilars Reimbursement Practive and Medicare

John Carlsen, MHA

Covance Market Access Services Inc., United States

Vice President

Leigh  Purvis, MPA

AARP’s Perspective on Access to Biologic Medicines

Leigh Purvis, MPA

American Association of Retired Persons (AARP), United States

Director, Health Services Research

Panel  Discussion

Panel Discussion

All Session Speakers, United States

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.